Search research articles
Contact Us
Filters
Showing results (391-400 of 422) with videos related to
Page
of 43
Sort By:
International Journal of Molecular Sciences
|
November 27, 2021
Modeling, Synthesis, and Biological Evaluation of Potential Retinoid-X-Receptor (RXR) Selective Agonists: Analogs of 4-[1-(3,5,5,8,8-Pentamethyl-5,6,7,8-tetrahyro-2-naphthyl)ethynyl]benzoic Acid (Bexarotene) and 6-(Ethyl(4-isobutoxy-3-isopropylphenyl)amino)nicotinic Acid (NEt-4IB)
Peter W Jurutka, Orsola di Martino, Sabeeha Reshi, et al.
The New England Journal of Medicine
|
November 1, 2018
Immune Escape of Relapsed AML Cells after Allogeneic Transplantation
Matthew J Christopher, Allegra A Petti, Michael P Rettig, et al.
International Journal of Molecular Sciences
|
December 23, 2022
An Isochroman Analog of CD3254 and Allyl-, Isochroman-Analogs of NEt-TMN Prove to Be More Potent Retinoid-X-Receptor (RXR) Selective Agonists Than Bexarotene
Peter W Jurutka, Orsola di Martino, Sabeeha Reshi, et al.
Blood Cancer Discovery
|
June 16, 2022
Convergent Clonal Evolution of Signaling Gene Mutations Is a Hallmark of Myelodysplastic Syndrome Progression
Andrew J Menssen, Ajay Khanna, Christopher A Miller, et al.
Journal of Medicinal Chemistry
|
September 1, 2023
Discovery of ABBV-154, an anti-TNF Glucocorticoid Receptor Modulator Immunology Antibody-Drug Conjugate (iADC)
Adrian D Hobson, Jianwen Xu, Dennie S Welch, et al.
BMJ Oncology
|
April 1, 2026
BASECAMP-1 screening study: a model for efficient enrolment in precision oncology clinical trials
J Randolph Hecht, Julian R Molina, Kirstin Liechty, et al.
Leukemia
|
October 4, 2024
Monitoring clonal burden as an alternative to blast count for myelodysplastic neoplasm treatment response
Meagan A Jacoby, Eric D Duncavage, Ajay Khanna, et al.
Ebiomedicine
|
August 1, 2022
Preclinical immunogenicity and efficacy of a candidate COVID-19 vaccine based on a vesicular stomatitis virus-SARS-CoV-2 chimera
Amy S Espeseth, Maoli Yuan, Michael Citron, et al.
Current Oncology (Toronto, Ont.)
|
November 12, 2019
Eastern Canadian Gastrointestinal Cancer Consensus Conference 2018
A J Hyde, R Nassabein, A AlShareef, et al.
JCO Precision Oncology
|
May 26, 2021
Impact of a 40-Gene Targeted Panel Test on Physician Decision Making for Patients With Acute Myeloid Leukemia
Erica K Barnell, Kenneth F Newcomer, Zachary L Skidmore, et al.
Page
of 43
Search research articles
Search
Showing results (391-400 of 422) with videos related to
Sort By:
Page
of 43
International Journal of Molecular Sciences
|
November 27, 2021
Modeling, Synthesis, and Biological Evaluation of Potential Retinoid-X-Receptor (RXR) Selective Agonists: Analogs of 4-[1-(3,5,5,8,8-Pentamethyl-5,6,7,8-tetrahyro-2-naphthyl)ethynyl]benzoic Acid (Bexarotene) and 6-(Ethyl(4-isobutoxy-3-isopropylphenyl)amino)nicotinic Acid (NEt-4IB)
Peter W Jurutka, Orsola di Martino, Sabeeha Reshi, et al.
The New England Journal of Medicine
|
November 1, 2018
Immune Escape of Relapsed AML Cells after Allogeneic Transplantation
Matthew J Christopher, Allegra A Petti, Michael P Rettig, et al.
International Journal of Molecular Sciences
|
December 23, 2022
An Isochroman Analog of CD3254 and Allyl-, Isochroman-Analogs of NEt-TMN Prove to Be More Potent Retinoid-X-Receptor (RXR) Selective Agonists Than Bexarotene
Peter W Jurutka, Orsola di Martino, Sabeeha Reshi, et al.
Blood Cancer Discovery
|
June 16, 2022
Convergent Clonal Evolution of Signaling Gene Mutations Is a Hallmark of Myelodysplastic Syndrome Progression
Andrew J Menssen, Ajay Khanna, Christopher A Miller, et al.
Journal of Medicinal Chemistry
|
September 1, 2023
Discovery of ABBV-154, an anti-TNF Glucocorticoid Receptor Modulator Immunology Antibody-Drug Conjugate (iADC)
Adrian D Hobson, Jianwen Xu, Dennie S Welch, et al.
BMJ Oncology
|
April 1, 2026
BASECAMP-1 screening study: a model for efficient enrolment in precision oncology clinical trials
J Randolph Hecht, Julian R Molina, Kirstin Liechty, et al.
Leukemia
|
October 4, 2024
Monitoring clonal burden as an alternative to blast count for myelodysplastic neoplasm treatment response
Meagan A Jacoby, Eric D Duncavage, Ajay Khanna, et al.
Ebiomedicine
|
August 1, 2022
Preclinical immunogenicity and efficacy of a candidate COVID-19 vaccine based on a vesicular stomatitis virus-SARS-CoV-2 chimera
Amy S Espeseth, Maoli Yuan, Michael Citron, et al.
Current Oncology (Toronto, Ont.)
|
November 12, 2019
Eastern Canadian Gastrointestinal Cancer Consensus Conference 2018
A J Hyde, R Nassabein, A AlShareef, et al.
JCO Precision Oncology
|
May 26, 2021
Impact of a 40-Gene Targeted Panel Test on Physician Decision Making for Patients With Acute Myeloid Leukemia
Erica K Barnell, Kenneth F Newcomer, Zachary L Skidmore, et al.
Page
of 43